TLPH CIK: 1427925

Talphera, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
50.5
FY22:
24.6
FY23:
11.6
FY24:
9.42
FY25:
20.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
27.4
FY22:
22.9
FY23:
8.82
FY24:
8.82
FY25:
8.82
Total assets
Change from FY21 to FY25
millions USD
FY21:
77.9
FY22:
47.5
FY23:
20.4
FY24:
18.2
FY25:
29.7

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
18.5
FY22:
13.8
FY23:
4.51
FY24:
2.65
FY25:
3.81
(negative)
Change from FY21 to FY25
millions USD
FY21:
95.3
FY22:
11.9
FY23:
1.78
FY24:
7.59
FY25:
8.88
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.9
FY22:
21.8
FY23:
14.1
FY24:
8.00
FY25:
17.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
77.9
FY22:
47.5
FY23:
20.4
FY24:
18.2
FY25:
29.7

All amounts in millions USD Data source:SEC EDGAR